Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
2183 | 2330 | 38.2 | 81% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
7 | 4 | INFECTIOUS DISEASES//MICROBIOLOGY//VIROLOGY | 1353914 |
29 | 3 | HIV//VIROLOGY//HIV 1 | 108954 |
773 | 2 | EFAVIRENZ//NEVIRAPINE//RALTEGRAVIR | 12242 |
2183 | 1 | HIV 1 PROTEASE//HIV PROTEASE//HIV 1 PROTEASE INHIBITORS | 2330 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | HIV 1 PROTEASE | authKW | 1643156 | 9% | 59% | 211 |
2 | HIV PROTEASE | authKW | 633052 | 4% | 52% | 93 |
3 | HIV 1 PROTEASE INHIBITORS | authKW | 455917 | 3% | 52% | 67 |
4 | EXPT RETROVIROL SECT | address | 223571 | 2% | 36% | 48 |
5 | RETROVIRAL PROTEASE | authKW | 147808 | 1% | 59% | 19 |
6 | HIV 1 PROTEINASE | authKW | 145145 | 1% | 92% | 12 |
7 | KNI 272 | authKW | 144139 | 0% | 100% | 11 |
8 | HIV PROTEINASE | authKW | 138401 | 1% | 81% | 13 |
9 | MOL BASIS DIS PROGRAM | address | 123754 | 1% | 41% | 23 |
10 | OLIGOPEPTIDE SUBSTRATES | authKW | 119121 | 0% | 91% | 10 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Chemistry, Medicinal | 15292 | 24% | 0% | 566 |
2 | Biochemistry & Molecular Biology | 5421 | 41% | 0% | 963 |
3 | Virology | 5058 | 12% | 0% | 270 |
4 | Chemistry, Organic | 2387 | 16% | 0% | 366 |
5 | Biophysics | 2349 | 12% | 0% | 288 |
6 | Biochemical Research Methods | 508 | 6% | 0% | 136 |
7 | Pharmacology & Pharmacy | 463 | 11% | 0% | 250 |
8 | Computer Science, Interdisciplinary Applications | 400 | 4% | 0% | 97 |
9 | Chemistry, Multidisciplinary | 203 | 9% | 0% | 213 |
10 | Infectious Diseases | 70 | 2% | 0% | 57 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | EXPT RETROVIROL SECT | 223571 | 2% | 36% | 48 |
2 | MOL BASIS DIS PROGRAM | 123754 | 1% | 41% | 23 |
3 | HIV AIDS MALIGNANCY BRANCH | 111334 | 2% | 16% | 52 |
4 | STRUCT BIOCHEM PROGRAM | 109987 | 1% | 44% | 19 |
5 | GENE MANIPULAT | 53500 | 0% | 58% | 7 |
6 | MOLEC VIROL CARCINOGENESIS | 53500 | 0% | 58% | 7 |
7 | MOL VIROL CARCINOGENESIS | 52406 | 0% | 50% | 8 |
8 | BIOCALORIMETRY | 47156 | 1% | 30% | 12 |
9 | BIOL MOL BASIS DIS | 41930 | 0% | 80% | 4 |
10 | RETROVIRAL DIS SECT | 39311 | 0% | 100% | 3 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | JOURNAL OF MEDICINAL CHEMISTRY | 17087 | 7% | 1% | 168 |
2 | BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 14178 | 7% | 1% | 166 |
3 | ANTIVIRAL CHEMISTRY & CHEMOTHERAPY | 6746 | 1% | 3% | 16 |
4 | PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS | 4271 | 2% | 1% | 46 |
5 | JOURNAL OF MOLECULAR GRAPHICS & MODELLING | 3359 | 1% | 1% | 22 |
6 | BIOORGANIC & MEDICINAL CHEMISTRY | 3077 | 2% | 0% | 56 |
7 | JOURNAL OF VIROLOGY | 2967 | 4% | 0% | 97 |
8 | CHEMICAL BIOLOGY & DRUG DESIGN | 2831 | 1% | 1% | 19 |
9 | PROTEIN SCIENCE | 2500 | 2% | 1% | 35 |
10 | JOURNAL OF CHEMICAL INFORMATION AND MODELING | 2387 | 1% | 1% | 24 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | HIV 1 PROTEASE | 1643156 | 9% | 59% | 211 | Search HIV+1+PROTEASE | Search HIV+1+PROTEASE |
2 | HIV PROTEASE | 633052 | 4% | 52% | 93 | Search HIV+PROTEASE | Search HIV+PROTEASE |
3 | HIV 1 PROTEASE INHIBITORS | 455917 | 3% | 52% | 67 | Search HIV+1+PROTEASE+INHIBITORS | Search HIV+1+PROTEASE+INHIBITORS |
4 | RETROVIRAL PROTEASE | 147808 | 1% | 59% | 19 | Search RETROVIRAL+PROTEASE | Search RETROVIRAL+PROTEASE |
5 | HIV 1 PROTEINASE | 145145 | 1% | 92% | 12 | Search HIV+1+PROTEINASE | Search HIV+1+PROTEINASE |
6 | KNI 272 | 144139 | 0% | 100% | 11 | Search KNI+272 | Search KNI+272 |
7 | HIV PROTEINASE | 138401 | 1% | 81% | 13 | Search HIV+PROTEINASE | Search HIV+PROTEINASE |
8 | OLIGOPEPTIDE SUBSTRATES | 119121 | 0% | 91% | 10 | Search OLIGOPEPTIDE+SUBSTRATES | Search OLIGOPEPTIDE+SUBSTRATES |
9 | DIMERIZATION INHIBITORS | 116730 | 1% | 64% | 14 | Search DIMERIZATION+INHIBITORS | Search DIMERIZATION+INHIBITORS |
10 | ASPARTIC PROTEASE | 89535 | 2% | 15% | 47 | Search ASPARTIC+PROTEASE | Search ASPARTIC+PROTEASE |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | GHOSH, AK , OSSWALD, HL , PRATO, G , (2016) RECENT PROGRESS IN THE DEVELOPMENT OF HIV-1 PROTEASE INHIBITORS FOR THE TREATMENT OF HIV/AIDS.JOURNAL OF MEDICINAL CHEMISTRY. VOL. 59. ISSUE 11. P. 5172 -5208 | 129 | 71% | 6 |
2 | KEMPF, DJ , SHAM, HL , (1996) HIV PROTEASE INHIBITORS.CURRENT PHARMACEUTICAL DESIGN. VOL. 2. ISSUE 2. P. 225 -246 | 158 | 86% | 93 |
3 | WLODAWER, A , VONDRASEK, J , (1998) INHIBITORS OF HIV-1 PROTEASE: A MAJOR SUCCESS OF STRUCTURE-ASSISTED DRUG DESIGN.ANNUAL REVIEW OF BIOPHYSICS AND BIOMOLECULAR STRUCTURE. VOL. 27. ISSUE . P. 249 -284 | 92 | 76% | 428 |
4 | GULNIK, S , ERICKSON, JW , XIE, D , (2000) HIV PROTEASE: ENZYME FUNCTION AND DRUG RESISTANCE.VITAMINS AND HORMONES - ADVANCES IN RESEARCH AND APPLICATIONS, VOL 58. VOL. 58. ISSUE . P. 213 -256 | 122 | 79% | 23 |
5 | WLODAWER, A , GUSTCHINA, A , (2000) STRUCTURAL AND BIOCHEMICAL STUDIES OF RETROVIRAL PROTEASES.BIOCHIMICA ET BIOPHYSICA ACTA-PROTEIN STRUCTURE AND MOLECULAR ENZYMOLOGY. VOL. 1477. ISSUE 1-2. P. 16 -34 | 87 | 94% | 127 |
6 | LEBON, F , LEDECQ, M , (2000) APPROACHES TO THE DESIGN OF EFFECTIVE HIV-1 PROTEASE INHIBITORS.CURRENT MEDICINAL CHEMISTRY. VOL. 7. ISSUE 4. P. 455 -477 | 114 | 73% | 55 |
7 | GHOSH, AK , ANDERSON, DD , WEBER, IT , MITSUYA, H , (2012) ENHANCING PROTEIN BACKBONE BINDINGUA FRUITFUL CONCEPT FOR COMBATING DRUG-RESISTANT HIV.ANGEWANDTE CHEMIE-INTERNATIONAL EDITION. VOL. 51. ISSUE 8. P. 1778 -1802 | 69 | 67% | 25 |
8 | DEBOUCK, C , (1992) THE HIV-1 PROTEASE AS A THERAPEUTIC TARGET FOR AIDS.AIDS RESEARCH AND HUMAN RETROVIRUSES. VOL. 8. ISSUE 2. P. 153 -164 | 83 | 75% | 314 |
9 | WLODAWER, A , ERICKSON, JW , (1993) STRUCTURE-BASED INHIBITORS OF HIV-1 PROTEASE.ANNUAL REVIEW OF BIOCHEMISTRY. VOL. 62. ISSUE . P. 543 -585 | 57 | 84% | 640 |
10 | HUANG, LQ , CHEN, CP , (2013) UNDERSTANDING HIV-1 PROTEASE AUTOPROCESSING FOR NOVEL THERAPEUTIC DEVELOPMENT.FUTURE MEDICINAL CHEMISTRY. VOL. 5. ISSUE 11. P. 1215 -1229 | 67 | 64% | 3 |
Classes with closest relation at Level 1 |